Feb 14, 2005, 08.19 PM | Source: Moneycontrol.com
Hyderabad based Zenotech Labs has cloned Genetech's blockbuster, Rituxan.
That's is not all, the company is already in discussions with an European drug giant to licence out the product.
Chigurupati said, "We have been in talks with a big European company with a generic arm with regards to giving our biologicals to them."
Going by the quality of researchers at Zenotech and the research product in the pipeline of Zenotech Labs, it could be the beginning of a strong future. But what really counts are the tedious regulatory processes involved in the regulatory approvals for biotech drugs.